Friday, December 13, 2019 10:11:37 AM
I hope that management will give it some time to see if the share price can actually climb and stabilize. The Preferred holders should like that better as well, increasing the value of their conversions.
And, what deals can you do in the future by paying with near-worthless Preferred shares masquerading as their perpetually and incredibly shrinking Common stock?
Just my opinion.
Always be on guard for misleading, deceptive or erroneous messages. I am not an investment professional. My messages are my opinion only, and are subject to change when contrary information is later relied upon. Always do your own research.
Recent CEI News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:30:23 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/22/2024 09:01:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 12:59:42 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/15/2023 09:16:32 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/18/2023 09:15:30 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/18/2023 09:15:17 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/26/2023 09:02:52 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/07/2023 12:00:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 08:09:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 01:00:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 12:02:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2023 12:40:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 12:38:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 12:44:26 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM